Bird Louise Elizabeth, Bilbrough Graham, Fitzgerald Ronan, Walker David John
Internal Medicine, Veterinary Specialist Services, Underwood, Queensland, Australia.
IDEXX Laboratories, Inc., Westbrook, Maine, USA.
Vet Rec Open. 2018 Feb 28;5(1):e000215. doi: 10.1136/vetreco-2016-000215. eCollection 2018.
To determine the time from treatment with a product containing imidacloprid 10 per cent/moxidectin 2.5 per cent spot-on (Advocate™), to dogs becoming negative for The authors hypothesised that most dogs would have resolution of within four weeks of treatment with Advocate™.
Prospective, non-randomised, prepost treatment study.
Cases were enrolled from general practices along the southern coast of the United Kingdom.
Nine dogs completed the study and were enrolled if had been diagnosed based on a positive commercially available, in-clinic, serological antigen test (Angio Detect) or Baermann performed at an external laboratory or both.
The only treatment positive dogs received was Advocate which was applied at the time of diagnosis and reapplied if necessary at four-weekly intervals until dogs tested negative by Angio Detect.
Angio Detect was performed and Advocate was reapplied at four-weekly intervals until dogs tested negative by this method.
Baermann was also performed at four-weekly intervals until dogs tested negative by this method.
Application of Advocate was an effective treatment for infection in dogs and resulted in resolution of the infection, based on Angio Detect testing and Baermann, within four weeks, in eight out of nine dogs. Post-treatment Angio Detect testing was concordant with Baermann in seven of nine dogs.
Application of Advocate™ was an effective treatment for infection in dogs and resulted in resolution of the infection within four weeks in most dogs. Repeat Angio Detect testing is recommended following treatment of to confirm resolution of the infection.
确定用含10%吡虫啉/2.5%莫昔克丁的滴剂(Advocate™)治疗后,犬只粪便中[具体寄生虫名称未给出]检测呈阴性所需的时间。作者假设,大多数犬只在用Advocate™治疗四周内粪便中[具体寄生虫名称未给出]会转阴。
前瞻性、非随机、治疗前后对照研究。
从英国南部海岸的普通诊所招募病例。
九只犬完成了研究,若根据市售的诊所内血清学[具体寄生虫名称未给出]抗原检测(Angio Detect)呈阳性,或在外部实验室进行的贝尔曼氏法检测呈阳性,或两者均呈阳性而诊断为[具体寄生虫感染名称未给出],则将其纳入研究。
阳性犬只接受的唯一治疗是Advocate,在诊断时应用,必要时每四周重复应用一次,直至犬只经Angio Detect检测呈阴性。
进行Angio Detect检测,每四周重复应用Advocate,直至犬只经该方法检测呈阴性。
每四周也进行一次贝尔曼氏法检测,直至犬只经该方法检测呈阴性。
基于Angio Detect检测和贝尔曼氏法,Advocate的应用是犬只[具体寄生虫感染名称未给出]感染的有效治疗方法,九只犬中有八只在四周内感染得到解决。九只犬中有七只治疗后的Angio Detect检测结果与贝尔曼氏法检测结果一致。
Advocate™的应用是犬只[具体寄生虫感染名称未给出]感染的有效治疗方法,大多数犬只在四周内感染得到解决。建议在治疗[具体寄生虫感染名称未给出]后重复进行Angio Detect检测,以确认感染已得到解决。